Gastroenterology Unit, Department of Biomedical and Clinical Sciences, "L. Sacco" University Hospital, Milan, Italy.
National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway.
Ultraschall Med. 2018 Jun;39(3):304-317. doi: 10.1055/s-0043-125329. Epub 2018 Mar 22.
The accuracy and usefulness of gastrointestinal ultrasound (GIUS) for detecting activity and complications of inflammatory bowel diseases (IBD), has been reported in studies, promoting this technique as an important tool for the management of IBD patients. Whilst well recognised by international guidelines, standardization and general agreement in the definition of the luminal and extra-intestinal features, still need to be well defined.A task force group of 17 experts in GIUS faced this issue, by developing recommendations and clinical guidelines for the use of GIUS in IBD, under the auspices of EFSUMB. This article presents the consensus on the current data on sonographic features of IBD and summarises the accuracy of different sonographic modalities for the management of IBD patients.
胃肠道超声（GIUS）在检测炎症性肠病（IBD）的活动和并发症方面的准确性和实用性已在研究中得到报道，促进了该技术成为 IBD 患者管理的重要工具。虽然国际指南已经充分认识到这一点，但在腔内腔外特征的定义方面仍需要进行标准化和普遍达成一致。一个由 17 名 GIUS 专家组成的工作组在 EFSUMB 的支持下，针对 GIUS 在 IBD 中的应用，制定了相关建议和临床指南，以应对这一问题。本文介绍了当前关于 IBD 超声特征的共识数据，并总结了不同超声模式在管理 IBD 患者方面的准确性。
